Cleared Traditional

K961206 - OPUS T3 CONTROLS

K961206 is an FDA 510(k) clearance for OPUS T3 CONTROLS, manufactured by Behring Diagnostics, Inc.. The device is a Class 1 Chemistry device with product code JJX cleared through the Traditional 510(k) pathway after a 27-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1996
Decision
27d
Days
Class 1
Risk

K961206 is an FDA 510(k) clearance for the OPUS T3 CONTROLS. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Behring Diagnostics, Inc. (Westwood, US). The FDA issued a Cleared decision on April 23, 1996 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Behring Diagnostics, Inc. devices

FDA 510(k) Submission Details - K961206

510(k) Number K961206 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 27, 1996
Decision Date April 23, 1996
Days to Decision 27 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d faster than avg
Panel avg: 88d · This submission: 27d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 445
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K961206.
LIQUISPEX URINE (MICRO)ALBUMIN CONTROL
K962432 · Clinical Controls, Inc. · Jul 1996
ACS FRT4 IMMUNOASSAY
K961510 · Ciba Corning Diagnostics Corp. · Jun 1996
COMPLEMENT CONTROL
K960874 · Wako Chemicals USA, Inc. · Jun 1996
ENA-C-T ASSAYED TOTAL CHOLESTEROL CONTROLS
K960378 · Actimed Laboratories, Inc. · Apr 1996
LXN FRUCTOSAMINE TEST
K955629 · Lxn Corp. · Mar 1996
PSA CONTROLS
K960154 · Diagnostic Products Corp. · Mar 1996